From Technology to AI: Navigating the Path Towards Decentralized Trials in Oncology

As the oncology field embraces the shift towards decentralized trials, understanding how to effectively leverage AI and technology is critical.

 
This webinar provides biotech and pharma companies with key insights for integrating innovative solutions into oncology clinical development.
  Key Takeaways Include:
  • The role of AI and technology in oncology trials
  • When to utilize hybrid and decentralized trial models
  • Strategic partner selection and vendor considerations
 

"*" indicates required fields

Please enter your details to get access to the resource

By submitting this form, you consent to your personal data submitted in the form being processed in alignment with our Online Privacy and Cookies policy. Your personal data will be processed to facilitate your request and may be used for sending you additional marketing and business development-related information about Ergomed, its affiliates, and our services. You can withdraw your consent anytime by messaging marketing@ergomedgroup.com, and we will promptly remove your data from our records. For more information about how we will process your personal data and your rights, please see our Online Privacy and Cookies policy.
This field is for validation purposes and should be left unchanged.